Self-sampling with the Delphi Screener further increases participation in the Finnish Cervical Cancer Screening Program

In 2011 researchers of the Mass Screening Registry at the Finnish Cancer Registry started a study among non-attendees of the cervical screening program in urban, semi-urban and rural areas of the country. Earlier, a successful pilot study in the urban municipality Espoo had shown that the Delphi Screener was a feasible option in enhancing attendance…

read more »

June 6, 2013

Robert Koch-Institute researchers presented results self-sampling study

Researchers from the Robert Koch-Institute, in cooperation with the Charité University clinic in Berlin, have presented additional results of the self-sampling study with the Delphi Screener amongst German women between the age of 20 and 25.  At the ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) 2013 in Berlin, Yvonne Deleré and Cornelis Remschmidt…

read more »

May 21, 2013

Thai Authorities launch dedicated website for cervical cancer screening with the Delphi Screener

On January 15, 2013, the novel cervical cancer screening method Delphi Screener was launched in Thailand. Thai authorities recognized the importance of the Delphi Screener as an additional way to provide screening for cervical cancer in a reliable and trusted way, especially for Thai women who do not regularly take  Pap smears. Thai authorities recently…

read more »

April 15, 2013

Cancer Society of the Ardennes includes Delphi Screener self-sampling method in French CervicalCancer screening pilot study

The National Cancer Institute in France (INCa) has asked the Cancer Society of the Ardennes Region (SAC08) to initiate a pilot study for population based cervical cancer screening. In this study, the Delphi Screener will be used as self-sampling method. The SAC08 (Dr. E Rousselot-Marche and Mrs. B Charlier), CHU Reims (Pr. C Clavel and…

read more »

March 22, 2013

Delphi Screener used in unique high-risk HPV prevalence study amongst pregnant women in Ethiopia

Ethiopia is facing high numbers of cervical cancer, caused by the high risk HPV (hrHPV). A better understanding of the burden of the virus types provides the opportunity to work on vaccination and screening initiatives. To obtain insight in the prevalence of hrHPV in women, a unique study on cervical cancer will be conducted amongst…

read more »

January 29, 2013

Thailand-Dutch collaboration launches unique self-Screening device to boost cervical cancer screening

On March 26 the launch of the Delphi Screener in Thailand has been taken place. -  Use-at-home Delphi Screener targets one-third of women in Thailand who are averse to Pap Smear - Cervical cancer still leading cause of death at Thai women aged 25-65 years old – Delphi Screener launch in Thailand leads roll-out to developing countries…

read more »

January 15, 2013

Press Releases Launch Delphi Screener Thailand

On January 15 the launch of the Delphi Screener inThailand has been taken place. ​Please find more information in the press releases below. http://www.thaipr.net/health/454023 or http://www.thaipost.net/x-cite/170113/68168

read more »

January 15, 2013

Delphi Screener highly rated by women during acceptance study in Rwanda

Delphi Bioscience partnered with a network of European and African university scientists in a study entitled: “Characterization of novel microbicide safety biomarkers in East and South Africa”. The Delphi Screener, an innovative medical device to collect vaginal samples, was made available for use within this study. A total of 60 Rwandan women used the Screener…

read more »

August 23, 2012

Detlef-Petzoldt-price with a study among German women with the Delphi Screener

German Robert Koch-Institut’s Dr. Yvonne Deleré has won the recognized Detlef-Petzoldt-price with a study among German women with the Delphi Screener. The prevalence of high risk Human Papilloma Virus in women between 20 and 25 years old has been investigated.” For more information http://dstig.de/index.php/aktuellespressekalender/87-and-the-winners-are

read more »

June 5, 2012

Delphi Screener successfully applied in clinical study

The Delphi Screener was successfully applied during a major clinical study conducted among 27,792 women. It appeared from the study that 30% of all women who do not have cervical smears taken by their doctors are willing to participate in tracing the human Papillomavirus (HPV) by means of home testing. HPV home testing is a…

read more »

May 29, 2012